318 : 639 Farlow MR, Lahiri DK, Poirier J, Davignon J, Schneider L, Hui SL
Food and Drug Administration (FDA) removed the prescribing restrictions associated with rosiglitazone following the release of the RECORD study, which showed that patients taking rosiglitazone were not at higher risk of heart attack or death compared with patients treated with other medications (hazard ratio [HR] = 0.99
Acetanilide was used as an internal standard and added to the sample before solid phase extraction (SPE) at a concentration of 100 M
Tobias DK, Merino J, Ahmad A et al (2023) Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine
These ingredients act on the part of the brain that regulates your appetite
W.QuirionR.ChronwallB.ChaseT